Cervical cytology automation: an update for 2003

Revealing the Disturbed Vaginal Micobiota Caused by Cervical Cancer Using High-Throughput Sequencing Technology

“…Cytopathological examination of cervical exfoliated cells were carried out using the Thin PrepPap test method which is approved by the US Food and Drug Administration (FDA) in 1996 ( Wilbur, 2003 ). Liquid-based cell treatment reagents was added to the obtained cervical exfoliated cells to lyse the red blood cells in the sample to avoid interference with the experimental results.…”

“…The PCR method is used to amplify the DNA fragments extracted from the samples, and the PCR product of about 200 bp was further mixed and reacted with the HPV DNA chip and its related reaction solution, and the result was interpreted after color development, so as to realize the detection of HPV type. HPV detection kit used in this experiment was purchased from Guangzhou LBP Medical Technology Co., Ltd. A total of 28 HPV subtypes were tested in this experiment, including high-risk types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82; and low-risk type 6, 11, 40, 42, 43, 44, 54, 61, 81, 83. Cytopathological examination of cervical exfoliated cells were carried out using the Thin PrepPap test method which is approved by the US Food and Drug Administration (FDA) in 1996 (Wilbur, 2003). Liquid-based cell treatment reagents was added to the obtained cervical exfoliated cells to lyse the red blood cells in the sample to avoid interference with the experimental results.…”

Συσχέτιση Παρουσίας Γονιδιώματος Θηλωματοϊών ( HPV) Και Αδενοεξαρτώμενων Ιών ( AAV ) Σε Φυσιολογικά Δυσπλαστικά Και Καρκινικά Επιχρίσματα Από Τον Τράχηλο Της Μήτρας

“…6% για τις ασθενείς με καρκίνο, τέταρτη ομάδα, με ποσοστό 82,4% αρνητικές στον ιό.Σε συσχέτιση με την ομάδα ελέγχου (17,8% θετικές και 82,2% αρνητικές στον ιό), το Fisher's exact test, δίνει τιμή p=0 523…”